Treatment of Steroid-resistant Pediatric Nephrotic Syndrome

Overview

Journal Korean J Pediatr

Specialty Pediatrics

Date 2011 Nov 17

PMID 22087197

Citations 4

Authors

Hee Gyung Kang

Affiliations

Soon will be listed here.

Abstract

Children who suffer from steroid-resistant nephrotic syndrome (SRNS) require aggressive treatment to achieve remission. When intravenous high-dose methylprednisolone fails, calcineurin inhibitors, such as cyclosporine and tacrolimus, are used as the first line of treatment. A significant number of patients with SRNS progress to end-stage renal disease if remission is not achieved. For these children, renal replacement therapy can also be problematic; peritoneal dialysis may be accompanied by significant protein loss through the peritoneal membrane, and kidney allograft transplantation may be complicated by recurrence of SRNS. Plasmapheresis and rituximab were initially used for treatment of recurrent SRNS after transplantation; these are now under consideration as rescue therapies for refractory SRNS. Although the prognosis of SRNS is complicated and unfavorable, intensive treatment in the early stages of the disease may achieve remission in more than half of the patients. Therefore, timely referral of pediatric SRNS patients to pediatric nephrology specialists for histological and genetic diagnosis and treatment is highly recommended.

Citing Articles

NPHS Mutations in Pediatric Patients with Congenital and Steroid-Resistant Nephrotic Syndrome.

Lee J, Tan Y, Ismail N Int J Mol Sci. 2024; 25(22).

PMID: 39596340 PMC: 11594456. DOI: 10.3390/ijms252212275.

Clinico-demographic and biochemical correlation of inflammatory gene expression in pediatric nephrotic syndrome.

Venkatachalapathy Y, Suresh P, Balraj T, Venkatesan V, Geminiganesan S, C D M Mol Biol Rep. 2024; 51(1):854.

PMID: 39060482 DOI: 10.1007/s11033-024-09784-z.

Management of Steroid-Resistant Nephrotic Syndrome in Children.

Sachdeva S, Khan S, Davalos C, Avanthika C, Jhaveri S, Babu A Cureus. 2021; 13(11):e19363.

PMID: 34925975 PMC: 8654081. DOI: 10.7759/cureus.19363.

Children with Steroid-Resistant Nephrotic Syndrome: A Single -Center Experience.

Pokrajac D, Kamber A, Karasalihovic Z Mater Sociomed. 2018; 30(2):84-88.

PMID: 30061794 PMC: 6029918. DOI: 10.5455/msm.2018.30.84-88.

References

Sharma M, Sharma R, McCarthy E, Savin V . The focal segmental glomerulosclerosis permeability factor: biochemical characteristics and biological effects. Exp Biol Med (Maywood). 2004; 229(1):85-98. DOI: 10.1177/153537020422900111. View

Lands L . New therapies, new concerns: rituximab-associated lung injury. Pediatr Nephrol. 2010; 25(6):1001-3. DOI: 10.1007/s00467-010-1476-3. View

McCarthy E, Sharma M, Savin V . Circulating permeability factors in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis. Clin J Am Soc Nephrol. 2010; 5(11):2115-21. DOI: 10.2215/CJN.03800609. View

Vecsei A, Muller T, Schratzberger E, Kircher K, Regele H, Arbeiter K . Plasmapheresis-induced remission in otherwise therapy-resistant FSGS. Pediatr Nephrol. 2001; 16(11):898-900. DOI: 10.1007/s004670100682. View

MENDOZA S, Reznik V, Griswold W, Krensky A, Yorgin P, Tune B . Treatment of steroid-resistant focal segmental glomerulosclerosis with pulse methylprednisolone and alkylating agents. Pediatr Nephrol. 1990; 4(4):303-7. DOI: 10.1007/BF00862503. View

Benoit G, Machuca E, Antignac C . Hereditary nephrotic syndrome: a systematic approach for genetic testing and a review of associated podocyte gene mutations. Pediatr Nephrol. 2010; 25(9):1621-32. PMC: 2908444. DOI: 10.1007/s00467-010-1495-0. View

Bensman A, Niaudet P . Non-immunologic mechanisms of calcineurin inhibitors explain its antiproteinuric effects in genetic glomerulopathies. Pediatr Nephrol. 2010; 25(7):1197-9. DOI: 10.1007/s00467-010-1469-2. View

Choudhry S, Bagga A, Hari P, Sharma S, Kalaivani M, Dinda A . Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial. Am J Kidney Dis. 2009; 53(5):760-9. DOI: 10.1053/j.ajkd.2008.11.033. View

Choi H, Lee B, Cho H, Moon K, Ha I, Nagata M . Familial focal segmental glomerulosclerosis associated with an ACTN4 mutation and paternal germline mosaicism. Am J Kidney Dis. 2008; 51(5):834-8. DOI: 10.1053/j.ajkd.2008.01.018. View

10.

Faul C, Donnelly M, Merscher-Gomez S, Chang Y, Franz S, Delfgaauw J . The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A. Nat Med. 2008; 14(9):931-8. PMC: 4109287. DOI: 10.1038/nm.1857. View

11.

Cho H, Lee J, Choi H, Lee B, Ha I, Choi Y . WT1 and NPHS2 mutations in Korean children with steroid-resistant nephrotic syndrome. Pediatr Nephrol. 2007; 23(1):63-70. DOI: 10.1007/s00467-007-0620-1. View

12.

Prytula A, Iijima K, Kamei K, Geary D, Gottlich E, Majeed A . Rituximab in refractory nephrotic syndrome. Pediatr Nephrol. 2009; 25(3):461-8. DOI: 10.1007/s00467-009-1376-6. View

13.

Nozu K, Iijima K, Fujisawa M, Nakagawa A, Yoshikawa N, Matsuo M . Rituximab treatment for posttransplant lymphoproliferative disorder (PTLD) induces complete remission of recurrent nephrotic syndrome. Pediatr Nephrol. 2005; 20(11):1660-3. DOI: 10.1007/s00467-005-2013-7. View

14.

Ingulli E, Tejani A . Incidence, treatment, and outcome of recurrent focal segmental glomerulosclerosis posttransplantation in 42 allografts in children--a single-center experience. Transplantation. 1991; 51(2):401-5. DOI: 10.1097/00007890-199102000-00025. View

15.

Lee H, Han K, Jung Y, Kang H, Moon K, Ha I . Variable renal phenotype in a family with an INF2 mutation. Pediatr Nephrol. 2010; 26(1):73-6. DOI: 10.1007/s00467-010-1644-5. View

16.

Mekahli D, Liutkus A, Ranchin B, Yu A, Bessenay L, Girardin E . Long-term outcome of idiopathic steroid-resistant nephrotic syndrome: a multicenter study. Pediatr Nephrol. 2009; 24(8):1525-32. DOI: 10.1007/s00467-009-1138-5. View

17.

Senggutuvan P, Cameron J, Hartley R, Rigden S, Chantler C, Haycock G . Recurrence of focal segmental glomerulosclerosis in transplanted kidneys: analysis of incidence and risk factors in 59 allografts. Pediatr Nephrol. 1990; 4(1):21-8. DOI: 10.1007/BF00858431. View

18.

Cheong H, Han H, Park H, Ha I, Han K, Lee H . Early recurrent nephrotic syndrome after renal transplantation in children with focal segmental glomerulosclerosis. Nephrol Dial Transplant. 1999; 15(1):78-81. DOI: 10.1093/ndt/15.1.78. View

19.

Hristea D, Hadaya K, Marangon N, Buhler L, Villard J, Morel P . Successful treatment of recurrent focal segmental glomerulosclerosis after kidney transplantation by plasmapheresis and rituximab. Transpl Int. 2006; 20(1):102-5. DOI: 10.1111/j.1432-2277.2006.00395.x. View

20.

Lee B, Ahn Y, Choi H, Kang H, Kim S, Cho B . Two Korean infants with genetically confirmed congenital nephrotic syndrome of Finnish type. J Korean Med Sci. 2009; 24 Suppl:S210-4. PMC: 2633182. DOI: 10.3346/jkms.2009.24.S1.S210. View